At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
Adderall capsule +1 moredrug
Likely dose
Adderall capsule 25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cardiovascular Effects of Adderall in Healthy Adults. A Randomized Clinical Trial.
In Brief
A Phase 4 clinical trial evaluating Adderall capsule and Placebo capsule for Hemodynamics and Cardiovascular System. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemodynamics, Cardiovascular System
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartJun 2018
Primary CompletionJul 2021
TodayJul 2026
First PostedDec 1, 2016
Enrollment StartJun 1, 2018
Primary CompletionJul 23, 2021
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 9.6 years ago
Interventions
Adderall capsuledrug
25 mg orally one time
Placebo capsuledrug
Looks exactly like the study drug, but it contains no active ingredient. Taken one time.